Read + Share
Amedeo Smart
Independent Medical Education
Spangle JM, Von T, Pavlick DC, Khotimsky A, et al. PIK3CA C-terminal frameshift mutations are novel oncogenic events that sensitize tumors to PI3K-alpha inhibition. Proc Natl Acad Sci U S A 2020;117:24427-24433.PMID: 32929011
Email
LinkedIn
Facebook
Twitter
Privacy Policy